Riken Vitamin Advances Toward Completion of ¥2 Billion Share Buyback Program

Riken Vitamin Co., Ltd. ( (JP:4526) ) has shared an update.

Riken Vitamin Co., Ltd. has reported progress on its ongoing share repurchase program, acquiring 57,300 shares of its common stock on the Tokyo Stock Exchange between February 1 and February 28, 2026, at a total cost of 179,067,993 yen. This buyback is part of a broader board-authorized program, under which the company has cumulatively repurchased 643,200 shares for 1,843,819,320 yen as of February 28, 2026, moving closer to its upper limit and signaling continued capital return efforts that may support shareholder value and share price stability.

The current buyback operates within a resolution approved on April 30, 2025, allowing the acquisition of up to 1,000,000 shares and 2 billion yen in total, via market purchases through March 24, 2026. By steadily executing this plan, Riken Vitamin is utilizing its balance sheet to adjust capital structure and demonstrate confidence in its long-term prospects, which can be viewed positively by investors focused on capital efficiency and equity returns.

The most recent analyst rating on (JP:4526) stock is a Buy with a Yen3550.00 price target. To see the full list of analyst forecasts on Riken Vitamin Co., Ltd. stock, see the JP:4526 Stock Forecast page.

More about Riken Vitamin Co., Ltd.

Riken Vitamin Co., Ltd. is a Japanese food and chemical manufacturer listed on the Tokyo Stock Exchange Prime Market under securities code 4526. The company is known for producing food ingredients, seasonings, and related products, serving both domestic and international markets with a focus on value-added functional materials.

Average Trading Volume: 56,296

Technical Sentiment Signal: Buy

Current Market Cap: Yen70.69B

For detailed information about 4526 stock, go to TipRanks’ Stock Analysis page.